178 related articles for article (PubMed ID: 24647927)
1. Primary hepatic sarcomatoid carcinoma: clinical features and prognosis of 28 resected cases.
Lu J; Zhang J; Xiong XZ; Li FY; Ye H; Cheng Y; Zhou RX; Lin YX; Cheng NS
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1027-35. PubMed ID: 24647927
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma].
Li Z; Huang Z; Bi X; Yang L; Zhao J; Zhao H; Zhang Y; Cai J; Zheng X
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):207-11. PubMed ID: 24785282
[TBL] [Abstract][Full Text] [Related]
3. Primary carcinosarcoma of the liver: clinicopathologic features of 5 cases and a review of the literature.
Lao XM; Chen DY; Zhang YQ; Xiang J; Guo RP; Lin XJ; Li JQ
Am J Surg Pathol; 2007 Jun; 31(6):817-26. PubMed ID: 17527068
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma and carcinosarcoma of the liver.
Wang QB; Cui BK; Weng JM; Wu QL; Qiu JL; Lin XJ
J Gastrointest Surg; 2012 Sep; 16(9):1715-26. PubMed ID: 22767081
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Sarcomatous Change in Patients with Hepatocellular Carcinoma After Surgical Resection.
Lu J; Xiong XZ; Li FY; Ye H; Lin YX; Zhou RX; Cai YL; Jin YW; Cheng NS
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1048-56. PubMed ID: 26286198
[TBL] [Abstract][Full Text] [Related]
6. Sarcomatous Components May Predict Prognosis in Patients with Pulmonary Pleomorphic Carcinoma.
Tagawa T; Morimoto J; Yoshida S; Yoshino I
Thorac Cardiovasc Surg; 2015 Oct; 63(7):614-7. PubMed ID: 25423314
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.
Huang SY; Shen SJ; Li XY
World J Surg Oncol; 2013 Oct; 11():252. PubMed ID: 24088577
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
[TBL] [Abstract][Full Text] [Related]
9. Esophageal carcinosarcoma: a unique entity with better prognosis.
Wang L; Lin Y; Long H; Liu H; Rao H; He Y; Rong T; Liang Y
Ann Surg Oncol; 2013 Mar; 20(3):997-1004. PubMed ID: 23010734
[TBL] [Abstract][Full Text] [Related]
10. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
11. Outcome after simultaneous resection of gastric primary tumour and synchronous liver metastases: survival analysis of a single-center experience in China.
Liu Q; Bi JJ; Tian YT; Feng Q; Zheng ZX; Wang Z
Asian Pac J Cancer Prev; 2015; 16(4):1665-9. PubMed ID: 25743789
[TBL] [Abstract][Full Text] [Related]
12. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases.
Lopez-Beltran A; Pacelli A; Rothenberg HJ; Wollan PC; Zincke H; Blute ML; Bostwick DG
J Urol; 1998 May; 159(5):1497-503. PubMed ID: 9554341
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.
Kim JM; Kwon CH; Joh JW; Ko JS; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
World J Surg Oncol; 2013 Apr; 11():92. PubMed ID: 23618082
[TBL] [Abstract][Full Text] [Related]
14. Surgical management and outcome of rectal carcinoids in a university hospital.
Wei R; Lo OS; Law WL
World J Surg Oncol; 2015 Feb; 13():31. PubMed ID: 25889934
[TBL] [Abstract][Full Text] [Related]
15. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases.
Ariyoshi K; Kawauchi S; Kaku T; Nakano H; Tsuneyoshi M
Histopathology; 2000 Nov; 37(5):427-36. PubMed ID: 11119124
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections.
Li M; Wang Z; Cao J; Han B; Zou H; Zang Y; Wu L
Eur J Surg Oncol; 2019 Sep; 45(9):1684-1690. PubMed ID: 31027944
[TBL] [Abstract][Full Text] [Related]
20. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence.
Ringe B; Wittekind C; Bechstein WO; Bunzendahl H; Pichlmayr R
Ann Surg; 1989 Jan; 209(1):88-98. PubMed ID: 2535924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
